2020
Resultado de búsqueda
Emmanuelle Marie Charpentier (French pronunciation: [emanɥɛl maʁi ʃaʁpɑ̃tje]; born 11 December 1968) is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin.
Emmanuelle Charpentier (Juvisy-sur-Orge, Francia; 11 de diciembre de 1968) es una microbióloga y bioquímica francesa. En 2020 fue galardonada con el Premio Nobel de Química «por el desarrollo de un método para edición genética», premio compartido con Jennifer Doudna. [1]
Prof. Emmanuelle Charpentier, Ph.D. Max Planck Unit for the Science of Pathogens. Charitéplatz 1. 10117 Berlin. +49 30 28460-410. contact@mpusp.mpg.de. Curriculum Vitae. Born 1968 in Juvisy-sur-Orge, France. Study of biology, microbiology, biochemistry and genetics at the University Pierre and Marie Curie (UPMC), Paris (1986-1992).
Emmanuelle is the inventor and co-owner of the core intellectual property of the CRISPR-Cas9 technology. Together with Rodger Novak and Shaun Foy, she co-founded CRISPR Therapeutics and ERS Genomics to develop the CRISPR-Cas genome engineering technology for biotechnology and biomedical applications.
Emmanuelle Charpentier. The Nobel Prize in Chemistry 2020. Born: 11 December 1968, Juvisy-sur-Orge, France. Affiliation at the time of the award: Max Planck Unit for the Science of Pathogens, Berlin, Germany. Prize motivation: “for the development of a method for genome editing”. Prize share: 1/2.
7 de oct. de 2020 · Prof. Emmanuelle Charpentier, Ph.D. Max-Planck-Forschungsstelle für die Wissenschaft der Pathogene. Charitéplatz 1. 10117 Berlin. +49 30 28460-410. contact@mpusp.mpg.de. Vita. Geboren 1968 in Juvisy-sur-Orge, Frankreich. Studium der Biologie, Mikrobiologie und Genetik an der Universität Pierre et Marie Curie, Paris (1986-1992).
Emmanuelle Charpentier was awarded the Nobel prize in Chemistry in 2020. She is a world-leading expert in regulatory mechanisms underlying processes of infection and immunity in bacterial pathogens.
